Jnba Financial Advisors Amgen Inc Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Amgen Inc stock. As of the latest transaction made, Jnba Financial Advisors holds 731 shares of AMGN stock, worth $215,301. This represents 0.02% of its overall portfolio holdings.

Number of Shares

731

Previous 731 -0.0%

Holding current value

$215,301

Previous $228,000 3.07%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $5,114 - $5,769	-20 Reduced 2.66%	731 $210,000
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $437 - $542	2 Added 0.27%	751 $201,000
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $9,427 - $11,148	44 Added 6.24%	749 $166,000
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $3,893 - $4,947	-17 Reduced 2.35%	705 $185,000
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $7,844 - $8,729	34 Added 4.94%	722 $176,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $34,206 - $37,840	-156 Reduced 18.48%	688 $166,000
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $62,599 - $69,449	-268 Reduced 24.1%	844 $206,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $11,095 - $12,930	50 Added 4.71%	1,112 $277,000
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $10,169 - $12,110	47 Added 4.63%	1,062 $244,000
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $3,133 - $3,755	18 Added 1.81%	1,015 $196,000
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $123,096 - $143,692	-690 Reduced 40.9%	997 $194,000
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $100,427 - $113,218	542 Added 47.34%	1,687 $350,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $5,930 - $6,930	-35 Reduced 2.97%	1,145 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,180	1,180 $203,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Amgen Inc Transaction History